Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.

Browsing by Subject "monoamine oxidase inhibitor"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Hospitalized Patients’ Perceived Knowledge and Risk of Monoamine Oxidase Inhibitor Medications Before and After a Pharmacist’s Classroom-Based Education
    (University of Minnesota, College of Pharmacy, 2010) Wenzel, Richard G.; Schommer, Jon C.
    Objective: Assess if a classroom-based pharmacy education service for hospitalized headache patients newly prescribed a monoamine oxidase inhibitor (MAOI) results in, 1) higher self-perceived medication knowledge, or 2) lower perceived risk of using MAOIs. Subjects: Individuals admitted to an inpatient headache unit over a five month period Methods: Patient survey administered before and after the education service to any patient newly prescribed an MAOI. Results: Seventy-eight individuals completed the study. Paired-samples t-tests showed that for each of the four items related to self-perceived medication knowledge, the scores reflected higher knowledge after the MAOI class compared to before the class (p < 0.05). For three out of the four items related to perceived risk of using MAOIs, the scores reflected a lower level of perceived risk after the MAOI class compared to before the class (p < 0.05). One item did not significantly change: “The MAOI prescribed for me is just as good as other products available for treating headache.” Conclusion: Our results demonstrate a pharmacist-conducted, classroom-based teaching method for newly prescribed MAOI patients can result in higher self-perceived medication knowledge and lower perceived risks.